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The cytokine IL-17 controls neutrophil-mediated
inflammatory responses. The pattern recognition
receptor(s) that induce Th17 responses during
infection, in the absence of artificial mitogenic stimu-
lation with anti-CD3/anti-CD28 antibodies, remain
obscure. We investigated the innate immune recep-
tors and pathogen-associated molecular patterns
involved in triggering Th17 responses during path-
ogen-specific host defense. The prototypic fungal
pathogen Candida albicans was found to induce
IL-17 more potently than Gram-negative bacteria.
Candida mannan, but not zymosan, b-glucans, Toll-
like receptor (TLR) agonists, or the NOD2 ligand
MDP, induced IL-17 production in the absence of
anti-CD3/anti-CD28 antibodies. Candida-induced
IL-17 responsewas dependent on antigen-presenting
cells and the macrophage mannose receptor (MR),
demonstrating that Candida mannan is not simply
a mitogenic stimulus. The TLR2/dectin-1 pathway,
but not TLR4 or NOD2, amplified MR-induced IL-17
production. This study identifies the specific pattern
recognition receptors that trigger the Th17 response
induced by a human pathogen in the absence ofmito-
genic stimulation.
INTRODUCTION
The recently described T helper 17 (Th17) cells produce inter-
leukin-17 (IL-17), a cytokine that is important in the host defense
against various pathogens (Ouyang et al., 2008), including
Gram-negative bacteria such as Kleibsiella pneumonia (Ye et al.,
2001) and Citrobacter rodentium (Mangan et al., 2006), the spiro-
chetal infection Borrelia burgdorferi (Infante-Duarte et al., 2000),
and the fungal pathogen C. albicans (Huang et al., 2004).
Candida-specific Th17 responses have also been observed in
peripheral blood in humans (Acosta-Rodriguez et al., 2007b). IL-
17 induces infiltration of polymorphonuclear leucocytes (PMNs)
at the site of infection, activation of tissue neutrophils and macro-Cellphages, and the synthesis of antimicrobial peptides (Ouyanget al.,
2008). Thesedata suggest an important role for the Th17 response
in the host defense against pathogens. However, overproduction
of IL-17 can also lead to autoimmune processes (Cua et al., 2003;
Fujino et al., 2003; Murphy et al., 2003), underscoring the delicate
balance in regulation of the Th17 response.
Recently, much has been learned about the cytokine profiles
that are needed to differentiate naive T cells into Th17 cells and
how to enable central memory T cells to secrete IL-17. Whereas
IL-1b alone is capable of inducing IL-17 secretion in human
central memory T cells (Acosta-Rodriguez et al., 2007a), IL-21
and TGF-b seem to be needed for driving differentiation of naive
T cells into Th17 cells (Yang et al., 2008). More controversial are
the receptor pathways that direct the immune response toward
a Th17 profile, with each of the TLRs (Evans et al., 2007), dec-
tin-1 (Leibundgut-Landmann et al., 2007), andNOD2 (van Beelen
et al., 2007) pathways individually being implicated in the induc-
tion of Th17 cells by different researchers. However, these
studies have used simultaneous stimulation of these receptors
with proliferation cocktails such as anti-CD3/anti-CD28, a model
with limited relevance for the in vivo situation. Little is known
about the interplay between the various receptor pathways of
the innate immune system that will eventually lead to a Th17
response during infection with human pathogens. In the present
study, we have focused on the induction of IL-17 by human
microbial pathogens and tried to clarify which innate immune
receptors and pathogen-associatedmolecular patterns (PAMPs)
are involved in triggering a Th17 response during the pathogen-
specific host defense. Surprisingly, we have identified the proto-
typic fungal pathogenC. albicans as amuchmore potent inducer
of IL-17 production compared to Gram-negative bacteria. The
most important pathway of IL-17 induction was represented by
the engagement of the macrophage mannose receptor (MR),
with the TLR2/dectin-1 pathway having a secondary amplifica-
tion effect on MR-induced IL-17 production.
RESULTS
Receptor- versus Proliferation-Dependent Induction
of IL-17 Production
Several receptor-dependent pathways have been described to
induce IL-17 production, such as dectin-1 (Acosta-RodriguezHost & Microbe 5, 329–340, April 23, 2009 ª2009 Elsevier Inc. 329
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Macrophage Mannose Receptor and Th17Figure 1. Receptor- versus Proliferation-Dependent Induction of
IL-17 Production
(A) Human PBMCs were stimulated for 5 days with RPMI, zymosan 100 mg/ml,
beads coated with anti-CD3, anti-CD28, or various combination, in the pres-
ence or absence of human serum. Production of IL-17 in the supernatants
was measured by ELISA.
(B) Human PBMCs were stimulated for 5 days in the presence of human serum
with TLR ligands (LPS 10 ng/ml, Pam3Cys 10 mg/ml, PolyI:C 10 mg/ml, Flagellin
10 mg/ml, and ODN M362 10 mg/ml), the NOD2 ligand MDP (10 mg/ml), or
anti-CD3/anti-CD28 (cell:bead ratio of 2:1). IL-6 and IL-17 were measured by
ELISA. All experiments were performed at least twice with a total of five healthy
volunteers. Data are pooled and expressed as mean ± SEM.et al., 2007b),NOD2 (vanBeelenet al., 2007), or TLRs (Evans et al.,
2007). However, all of these studies have used combinations of
receptor ligands and proliferation stimuli such as anti-CD3/anti-
CD28 (aCD3/aCD28) antibodies. We wanted to differentiate the
relative importance of the receptor-specific and proliferation-
dependent induction of IL-17 by stimulating cells with a known
IL-17 inducer, zymosan, in the presence or absence of aCD3/
aCD28. Zymosan alone was able to induce only very limited
amounts of IL-17 in the presence of human serum, and anti-CD3
as a costimulatory signal was needed in order to potentiate the
zymosan-induced IL-17 production (Figure 1A). The nonspecific
stimuli aCD3/aCD28, in the presence of serum, induced the high-
est amount of IL-17 secretion (Figure 1A). To investigate whether
TLR and NLR ligands alone were able to induce IL-17 production,
PBMCs were stimulated with a TLR2 ligand (Pam3Cys 10 mg/ml),
TLR4 ligand (LPS 10 ng/ml), TLR3 ligand (PolyI:C 10 mg/ml),
TLR5 ligand (flagellin 10 mg/ml), TLR9 ligand (ODN 10 mg/ml), and
the NOD2 ligandMDP (10 mg/ml) in the presence of human serum,
without additional costimulatory factors. No single ligandwas able
to induce IL-17 production, although all ligands were able to
induce IL-6 production (Figure 1B). Several combinations of these330 Cell Host & Microbe 5, 329–340, April 23, 2009 ª2009 Elsevier Iligands (TLR2 with TLR4, TLR2 with NOD2, and TLR4 with NOD2)
were also not able to induce IL-17 production in human PBMCs
(data not shown). Thus, stimulation of TLRs and NOD2 pathways
alone cannot induce production of IL-17.
Pathogen-Induced Production of IL-17
IL-17 is important in the host defense against extracellular bacte-
rial and fungal infections (Happel et al., 2003; Ye et al., 2001). We
investigated the capacity of whole microorganisms to induce
IL-17 production. Both Gram-negative and fungal pathogens
induced IL-17 secretion. However, C. albicans was by far the
most potent inducer of IL-17 production, in concentrations
comparable to those induced by aCD3/aCD28 antibodies. In
contrast, comparable amounts of monocyte-derived IL-1b,
a cytokine known to be important for the induction of IL-17,
were induced by Gram-negative bacteria and C. albicans
(Figure 2A). Because bacteria and fungi differ in size and there-
fore in surface area and antigen load, we compared high
dosages of Gram-negative bacteria with low dosages of fungi.
Even a 1000-fold higher concentration of Gram-negative
bacteria was still less potent in the induction of IL-17 production
(data not shown). RT-PCR showed that the induced IL-17 mRNA
was accompanied by upregulation of RORgt (Figure 2B). The
conidial form ofC. albicanswas themost potent for the induction
of IL-17 (Figure 2A), and both heat-killed and live C. albicans
induced significant amounts of IL-17 (Figure 2C). Cytokine
kinetics during these stimulations showed that IL-17 increased
steadily during the 7 day period, while IL-23 production was
maximal in the first 24 hr and decreased thereafter (Figure 2D).
IL-10 was present in the first 48 hr and decreased to undetect-
able limits at day 3 and stayed undetectable (Figure 2D). IFNg
was present at 48 hr and reached itsmaximum at 4–5 days, while
IL-1b reached its maximum level at 24 hr, after which a plateau
was attained (Figure 2D). At day 5 of stimulation, flow cytometry
of PBMCs stimulated with C. albicans yeast cells showed
a subset of CD4+ cells that was capable of producing IL-17 alone
or in combination with IFNg (Figures 2E and 2F).
The Mannose Receptor Is Crucial for the Induction
of IL-17 Production by C. albicans
The structure of theC. albicans cell wall is very different from that
of bacteria, being composed of polysaccharides such as
mannans, b-glucans, and chitin (Bowman and Free, 2006).
Single fungal components were tested for the induction of
IL-17. C. albicans mannan, but not S. cerevisiae mannan, was
able to induce IL-17 production (Figure 3A). Surprisingly, the
other fungal components, b-glucan and chitin, did not induce
IL-17 production. Although zymosan was able to induce IL-1b,
it did not lead to a significant production of IL-17 (Figure 3A).
C. albicans mannan showed a dose-dependent induction of
IL-17 production (Figure 3A). C. albicans mannan did not stimu-
late IL-17 production in the absence of serum (data not shown).
Subsequently, we assessed the receptors leading to IL-17
production in human PBMCs by blocking them with specific
antibodies. Blocking of the MR resulted in the strongest inhibi-
tion of IL-17 production, and quantitative RT-PCR showed that
mRNA for IL-17A and RORgt were downregulated in the pres-
ence of the MR inhibitor (Figures 3B and 3C). Blocking of the
dectin-1/TLR2 pathway also led to partial inhibition of IL-17nc.
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(A) Human PBMCs were stimulated for 5 days with RPMI or several pathogens. IL-1b and IL-17 were measured by ELISA. n = 10; data are pooled and expressed
as mean ± SEM.
(B) RT-PCR of the expression of RORgt and IL-17A in PBMCs stimulated with RPMI or C. albicans for 3 days. Data are given as relative mRNA expression
(2-DCT 3 1000) and expressed as median from two separate experiments (n = 3).
(C) PBMCs stimulated for 5 days with either live C. albicans (105/ml) or heat-killed (HK) C. albicans (105/ml). n = 10; data are pooled and expressed as mean ±
SEM.
(D) Time course of IL-17 production in human PBMCs stimulated with heat-killed C. albicans yeasts or pseudohyphae. Cyokines were measured by ELISA. Data
are from one healthy volunteer and represent the pattern observed in two separate experiments, with a total of n = 5.
(E) Intracellular cytokine staining of IL-17 and IFNg in human PBMCs (n = 5) stimulated for 5 days with RPMI or C. albicans and then stimulated for 4 hr with PMA
and ionomycin. Cells were gated for CD4, and data is given as percentage of total gated CD4+ cells.
(F) Representative intracellular cytokine staining of IL-17 and IFNg for data given in (E). Data are from one healthy volunteer and represent the pattern observed in
two separate experiments, with a total of n = 5.production (Figure 3C). Blocking of TLR4 had no effect on
Candida mannan-induced IL-17 secretion (Figure 3C). This was
not due to the loss of functional blocking by the inhibitor on
day 5, since LPS-induced IL-1b production was still inhibited
by TLR4 blocking after 5 days (data not shown). Furthermore,
C. albicans was able to induce pro- and anti-inflammatory cyto-
kines (Figure 3D). Interestingly, in the presence of the anti-MR,
there was no effect on IL-12, IL-23, IL-2, IL-1b, TNF-a, and
IFNg production, but there was a significant reduction in IL-10Cell(Figure 3D). Next, we determined if the observed lower IL-17
production was in line with a lower induction of IL-17-producing
cells. We observed that blocking the MR inhibited the
percentage of CD4+ IL-17-producing cells (Figures 3E and 3F).
SinceS.cerevisiaemannan itself cannot induce IL-17production,
but is able to interactwith theMR,wepreincubatedPBMCswith an
excess of S. cerevisiaemannan (Figure 4A). This inhibited the IL-17
production induced by C. albicans mannan and C. albicans. To
further establish thatC. albicansmannan induces a Th17 responseHost & Microbe 5, 329–340, April 23, 2009 ª2009 Elsevier Inc. 331
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Macrophage Mannose Receptor and Th17Figure 3. The Mannose Receptor Is the Main Receptor Pathway for the Induction of IL-17 Production by C. albicans
(A) Human PBMCswere stimulated for 5 days with RPMI, several fungal components (in a concentration of 10 mg/ml), or zymosan 100 mg/ml. Mannanwas given in
different concentrations (mg/ml). IL-1b and IL-17 were measured by ELISA.
(B) RT-PCR of the expression of RORgt and IL-17A in PBMCs stimulated with RPMI or C. albicans at 3 days in the presence or absence of the blocking antibody
for MR (aMR). Data are given as relative mRNA expression (2-DCT 3 1000) and expressed as median; two separate experiments n = 3.
(C) Human PBMCs were stimulated for 48 hr with RPMI as a control or heat-killed C. albicans yeast cells in the presence or absence of blocking antibodies and
isotype controls. For (A)–(C), data are pooled from at least two separate experiments with a total of six healthy volunteers (mean ± SEM).
(D) Human PBMCs were stimulated for 5 days with heat-killed C. albicans yeast cells in the presence or absence of specific receptor inhibitors and isotype
controls.
(E) Intracellular cytokine staining of IL-17 and IFNg in human PBMCs (n = 5) stimulated for 5 days withC. albicans in the presence or absence of the aMR and than
stimulated for 4 hr with PMA and ionomycin. Cells were gated for CD4, and data are given as percentage of total gated CD4+ cells.
(F) Representative intracellular cytokine staining of IL-17 and IFNg for data given in (D). Data are fromonehealthy volunteer and represent thepattern observed in (E).specifically through the MR, we investigated the effect of siRNA
depletion of the MR from monocytes. Levels of MR mRNA was
strongly reduced by the siRNA (Figure 4B), and FACS analysis
also demonstrated decreased expression of MR on the cell
membrane (Figure4C). The IL-17production inducedbyC.albicans
mannan was reduced by roughly 50% in PBMCs treated with MR
siRNA (Figure 4D). In contrast, immunoglobulins are not involved
in the induction of IL-17 byC. albicans, as serum from both control
individuals or patients with X-linked agammaglobulinemia (XLA)
was equally potent to support the production of IL-17 (Figure 4E).
IL-17 Production Induced by C. albicans and Mannan
Is Monocyte Dependent
It is known that fungal mannans contain immunodominant T cell
epitopes (Pietrella et al., 2008) and that Candida can directly
interact with lymphocytes (Forsyth and Mathews, 2002). We332 Cell Host & Microbe 5, 329–340, April 23, 2009 ª2009 Elsevier Intherefore investigated whetherC. albicans or purifiedC. albicans
mannan alonewas able to directly activate T cells andwould lead
to the production of IL-17. Neither naive nor memory CD4+
T cellswere able to produce IL-17when stimulated in the absence
of antigen-presenting cells (APC) (Figure 5A). We therefore
explored the role of APCs for the induction of IL-17. Monocytes
were isolated and stimulated with C. albicans or C. albicans
mannan in the presence or absence of naive or memory T cells.
We demonstrate that monocytes alone were not able to produce
IL-17, but the coculture of monocytes with memory CD4+ T cells
induced a strong Th17 response (Figure 5B).
Dectin-1-Deficient PBMCs Have a Relatively Lower
Th17 Response to C. albicans Yeasts
The in vitro stimulations described above suggest that although
b-glucan by itself cannot stimulate IL-17 production, thec.
Cell Host & Microbe
Macrophage Mannose Receptor and Th17Figure 4. Blocking the MR with S. cerevisiae Mannan and Inhibiting MR Expression Using siRNA Transfection
(A) HumanPBMCswere preincubated for 1 hr with 100 mg/ml ofS. cerevisiaemannan and stimulated for 5 days with RPMI,C. albicansmannan (10 mg/ml), or heat-
killed C. albicans.
(B) RT-PCR for the expression ofMR in cells transfected with control siRNA and MR siRNA. (A) and (B) had a total of five healthy volunteers. Data are pooled and
expressed as mean ± SEM.
(C) Flow cytometry: expression of the MR on the cell surface of cells stimulated for 5 days with 10 mg/ml of C. albicans mannan that were treated with control
siRNA (black line) or MR siRNA (dotted gray line). Data are shown from one volunteer, representative for all volunteers.
(D) IL-17 production in cells transfected with control siRNA or MR siRNA and stimulated with RPMI or C. albicans mannan.
(E) IL-17 production induced in the presence of serum isolated from healthy volunteers or from a patient with XLA with immunoglobulin deficiency. (D) and (E) had
a total of five healthy volunteers. Data are pooled and expressed as mean ± SEM.dectin-1/TLR2 pathway can still contribute to the IL-17 induction
by C. albicans, possibly by potentiating other routes of stimula-
tion. To assess whether this is the case in patients, we investi-
gated IL-17 production in three patients with a complete defect
in dectin-1 expression due to an eary-stop codon mutation
(Tyr238Stop) (B. Ferwerda, G. Ferwerda, T. Plantinga, J.A. Will-
ment, A.B. van Spriel, H. Venselaar, A. Cambi, C. Huysamen,
L. Jacobs, T. Jansen, K. Verheijen, L. Masthof, G. Vriend,
D.L.W., L.A.B.J., J.W.M.v.d.M., G.J. Adema, B.J.K., G.D. Brown,
and M.G.N., unpublished data). FACS analysis confirmed that
the cells of the three patients used in these experiments
expressed no dectin-1 on their surface (Figure 6A). Dectin-1-
deficient PBMCs showed a lower IL-17 production compared
to healthy controls when stimulated with C. albicans yeasts
(Figure 6B), but not in pseudohyphae that do not express
b-glucans on their surface (Gantner et al., 2005). The normal
pattern of a higher IL-17 production induced byC. albicans yeast
cells compared to pseudohyphae was lost in PBMCs that wereCeldectin-1 deficient. IL-1b and IL-6 induction by C. albicans was
also defective in these patients (data not shown). On the other
hand, Candida mannan induced significant IL-17 production
in PBMC isolated from two dectin-1-deficient patients
(Figure 6C), demonstrating that the observed induction of IL-17
by Candida mannan is not through dectin-1. Furthermore,
IL-17 release induced by heat-killed C. albicans was strongly in-
hibited by the blockade of MR even in the cells defective for dec-
tin-1, demonstrating that IL-17 production is largely dependent
on the MR in the absence of dectin-1 (Figure 6D).
TLR2 Is Synergistic with the Mannose Receptor
for IL-17 Production
Dectin-1 is known to associate with TLR2 and can induce syner-
gistic effects on TLR2 responses (Brown et al., 2003; Gantner
et al., 2003). In order to assess whether stimulation of both
receptors could induce IL-17, we tested the combination of
b-glucan with a TLR2 ligand (Pam3Cys). Although b-glucansl Host & Microbe 5, 329–340, April 23, 2009 ª2009 Elsevier Inc. 333
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Macrophage Mannose Receptor and Th17Figure 5. IL-17 Production Induced by C. albicans and Mannan Is Monocyte Dependent
(A) CD4+ naive (CD25-CD45RA+) and CD4+ memory (CD25-CD45RA) T cells (2.53 104) were cultured with or without autologous monocytes (1.0 3 105) and
stimulated for 8 days with culture medium, C. albicans mannan, or heat-killed C. albicans. IL-17 was measured in supernatants by ELISA.
(B) Density plots show intracellular IL-17 staining of the same experiment as shown in (A). T cells were gated on CD3; CD14+monocytes were CD3-negative. Data
are representative for two identical, separate experiments.synergized with Pam3Cys for the production of IL-1b, IL-10,
IFNg, and TNF-a, no IL-17 production was induced by this
combination of stimuli (Figure 7A). Preparations of b-glucans
(b-glucan or curdlan) were not able to stimulate IL-17 production
either alone or in combination with C. albicansmannan (data not
shown). This is most likely due to the requirement of spatial
presentation of the b-glucans in the fungal cell wall, stimulating
dectin-1 more efficiently compared to the purified b-glucan
preparations. Surprisingly, although Pam3Cys alone was not
capable of inducing IL-17, combining Pam3Cys with C. albicans
mannan resulted in strong synergism for IL-17 production
(Figure 7A). RT-PCR demonstrated that upregulation of mRNA
for IL-17 was also synergistic (Figure 7B). Interestingly, the
mannan-induced IFNg and IL-1b was significantly inhibited by
stimulating the TLR2 pathway, while the production of IL-10
and TNF-a by Candida mannan was unaffected by Pam3Cys
(Figure 7C).334 Cell Host & Microbe 5, 329–340, April 23, 2009 ª2009 Elsevier InDISCUSSION
IL-17 has emerged as one of the most important proinflamma-
tory cytokines due to its modulation of neutrophil-mediated
responses, with important roles for both host defense (Happel
et al., 2003; Huang et al., 2004; Ye et al., 2001) and autoimmunity
(Cua et al., 2003; Fujino et al., 2003; Murphy et al., 2003). While
most studies to date have focused on the conditions (cytokine
profiles) necessary for generating Th17 cells in vitro (Acosta-
Rodriguez et al., 2007a; Yang et al., 2008) or the generation of
Th17 cells in mice (Bettelli et al., 2006; Korn et al., 2007), very
little is known about the pathways regulating IL-17 upon the
encounter of pathogenic microorganisms by human cells. In
addition, in order to stimulate IL-17 production, these studies
have used aCD3/aCD28 antibodies for inducing T cell prolifera-
tion, artificial conditions obviously not encountered during in vivo
infections or inflammation. In the present study, we havec.
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Macrophage Mannose Receptor and Th17Figure 6. Dectin-1-Deficient PBMCs Have a Relatively Lower Th17 Response to C. albicans Yeasts
(A) Flow cytometry of the expression of dectin-1 on the surface of PBMCs isolated from healthy volunteers (C1 andC2) and from three individuals homozygous for
the Tyr238 stop mutation (P1–P3).
(B) PBMCs described in (A) were stimulated for 5 days with heat-killed C. albicans yeasts or pseudohyphae.
(C) Candidamannan induced significant IL-17 production in PBMCs isolated from control volunteers (black bars) as well as from two dectin-1-deficient patients
(gray bars).
(D) IL-17 release induced by heat-killed C. albicans was strongly inhibited by the blockade of MR in both control (black bars) and dectin-1-deficient (gray bars)
PBMCs. For (C) and (D), data are pooled and expressed as mean ± SEM. IL-17 was measured by ELISA.investigated the pathways of IL-17 stimulation by human primary
cells stimulated with whole microorganisms, conditions that
mimic real-life infections. In addition, we deciphered the
receptor-ligand pathways responsible for IL-17 induction by the
fungal pathogen C. albicans. We demonstrate that C. albicans
is the most potent pathogen in eliciting a pathogen-mediated
Th17 response in human PBMCs in the absence of anti-CD3
and/or anti-CD28 antibodies. The MR is the main pathway
through which C. albicans induces the Th17 response. While
no single TLR or NOD2 ligand was able to induce IL-17 in the
absence of aCD3/aCD28 antibodies, mannan from C. albicans
was the only component capable of inducing IL-17 secretion.
Interestingly, the dectin-1/TLR2 pathway was able to synergize
with the MR-induced IL-17 secretion, revealing an interactionCellbetween C-type lectin receptors and TLRs. These data imply
that direct recognition through the MR is sufficient for inducing
a Th17 response, and that this ability is unique to the MR within
the family of pattern recognition receptors.
Using anti-CD3 or a combination of anti-CD3 and anti-CD28
antibodies in order to investigate the pathways leading to the
generation of Th17 cells, several studies suggested that dec-
tin-1 (Leibundgut-Landmann et al., 2007), NOD2 (van Beelen
et al., 2007), or TLR (Evans et al., 2007) receptors specifically
induce Th17 generation. However, these results are potentially
biased by the use of anti-CD3 and anti-CD28 antibodies that
can, by themselves, induce IL-17, as clearly demonstrated by
our results. In this study, we did not use aCD3/aCD28 antibodies
to investigate the IL-17 responses to specific pathogens orHost & Microbe 5, 329–340, April 23, 2009 ª2009 Elsevier Inc. 335
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induction of IL-17 in human cells by pathogens alone. Human
serum alone did not induce IL-17 secretion in human PBMCs,
but was able to optimize the conditions needed for the induction
of a Th17 response. Recently, it has been speculated that serum
contains small amounts of TGF-b that may be responsible for the
observed differences between IL-17 production of cells cultured
in the absence or presence of human serum (Manel et al., 2008).
Furthermore, we have addressed the role of serum antibodies in
our experiments by using serum from patients with XLA. These
patients cannot produce antibodies, because they lack func-
tional B cells. No differences were observed between pooled
serum and XLA serum devoid of antibodies, concluding that
IL-17 production was not antibody dependent. Notably, in the
absence of aCD3/aCD28, we show that no single TLR or
NOD2 ligand was able to induce IL-17 production in human
PBMCs.
IL-17 is important for the host defense against human patho-
gens (Huang et al., 2004; Ye et al., 2001). Although both Gram-
negative bacteria and the fungus S. cerevisiae were able to
induce IL-17 production in human PBMCs, C. albicans was by
far the most potent inducer of IL-17 secretion. The IL-17 produc-
tion correspondedwith the appearance of a subset of CD4+ cells
that contained cells capable of producing IL-17 or both IFNg and
IL-17. Since C. albicans was the most potent inducer of IL-17
production, we wanted to further dissect the pathways respon-
sible for inducing the Th17 response by this fungal pathogen.
When purified fungal components were tested, we observed
Figure 7. TLR2 Is Synergistic with the Mannose
Receptor for IL-17 Production
(A) Human PBMCs were stimulated for 5 days with RPMI,
fungal components, or/and the TLR2 ligand Pam3Cys. IL-17
was measured by ELISA. Data are pooled from at least two
separate experiments with a total of six healthy volunteers
(mean ± SEM).
(B) RT-PCR of the expression of IL-17A in PBMCs stimulated
with RPMI, Pam3Cys and mannan, or combinations for
3 days. Data are given as relative mRNA expression (2-DCT 3
1000) and are expressed as median; two separate experi-
ments n = 3.
(C) Human PBMCs were stimulated for 48 hr with the same set
of stimuli used in (B), and IL-1b, IL-10, IFNg, and TNF-a were
measured by ELISA. Data are pooled from at least two sepa-
rate experiments with a total of six healthy volunteers (mean ±
SEM).
a strong IL-17 production in PBMCs upon stimula-
tion with C. albicansmannan. This is in line with the
fact that live Candida was even more potent in the
induction of IL-17 production compared to heat-
killed yeasts, since mainly mannoproteins are
exposed when live Candida is used as a stimulus.
Interestingly, S. cerevisiae mannan was not able
to induce IL-17, and this is in line with the absent
Th17 response to zymosan, as zymosan is derived
from S. cerevisiae cell wall. The differential recogni-
tion of mannans from C. albicans and Saccharo-
myces is most likely due to the different branching
of these structures: whileCandida-derivedmannan
has a highly branched structure, Saccharomycesmannanmainly
contains short linear chains of mannose polymers (Cambi et al.,
2008). These data argue that the MR is able to coordinate the
different responses to fungal pathogens, particularly regarding
the Th17 response. To investigate further the receptor pathways
responsible for IL-17 induction by Candida, the main receptors
involved in fungal recognition were blocked with specific anti-
bodies before stimulation of IL-17 was triggered. In line with
the effects of Candida mannan, blocking of the MR resulted in
the strongest inhibition of IL-17 production, confirming its impor-
tant role in the Th17 response toC. albicans. Blockade of MR did
not only result in a lower amount of IL-17, but also led to a lower
percentage of CD4+ cells that were able to produce IL-17 alone
or the combination of IFNg and IL-17. Furthermore, blocking the
MR with an excess of S. cerevisiae mannan or decreasing the
MR expression with siRNA also inhibited IL-17 production.
It has been demonstrated in the literature that mannoproteins
contain immunodominant T cell epitopes (Pietrella et al., 2008).
Several mannoproteins, among them mannoprotein 65 kDa
(MP65), stimulate T cell proliferation through their protein parts,
with the mannan component being responsible for the cytokine
induction (Pietrella et al., 2006). Indeed, recombinant MP65
devoid of its mannan structure was unable to stimulate cytokine
production (Pietrella et al., 2008). We havemeasured the amount
of protein in our highly purified C. albicans mannan preparation.
Despite the extensive purification procedures, we have
measured a quantity of 0.77 mg/ml protein in the C. albicans
mannan preparation with a concentration of 100 mg/ml. Although336 Cell Host & Microbe 5, 329–340, April 23, 2009 ª2009 Elsevier Inc.
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proteins used in the literature, which have a protein-to-polysac-
charide ratio of 1.8:1 (Chaffin et al., 1998), we cannot exclude
that these protein components induced TCR-dependent cell
proliferation. These effects, due to Candida-specific epitopes,
may in fact explain why the memory T cells were by far more
effective for the release of IL-17 in comparison with the naive
T cells. Therefore, we envisage a model in which TCR-depen-
dent effects are responsible for T cell activation/proliferation,
while the mannan/MR interaction induces the skewing of this
population toward a Th17 phenotype. Saccharomyces mannan
also contained these low amounts of protein. However, it did
not stimulate IL-17 release, most likely due to the important
differences in the branching of the mannan structures that do
not allow proper stimulation of MR by Saccharomyces mannan
(Cambi et al., 2008).
When cells were stimulated with a combination of TLR ligands
or TLR ligands with the NOD2 ligand MDP, no IL-17 production
was observed in human PBMCs. Blockade of the TLR2/dectin-1
pathway partially inhibited IL-17 production, while TLR4 blockade
had no effect. Stimulation of cells with both TLR2 and dectin-1
ligand, alone or in combination, did not result in IL-17 production,
although synergism for the production of other cytokines has been
previously reported (Gantner et al., 2003) and confirmed in our
study. Interestingly, TLR2 showed a specific synergistic effect
on the IL-17 production induced by the MR, while no such effect
was apparent on IL-1bproduction. The role of dectin-1was further
investigated by stimulating PBMCs isolated from individuals
homozygous for an early stop codon mutation in the dectin-1
gene, which leads to a total loss of dectin-1 activity (data not
shown).When compared to cells isolated fromhealthy volunteers,
the dectin-1-deficient PBMCs released less IL-17 after stimulation
with C. albicans. The role of dectin-1 for the amplification of IL-17
production is supported by an additional line of evidence. We
observed that the Th17 response induced by C. albicans yeast
cells was stronger than the Th17 response induced by albicans
pseudohyphae. The fact that C. albicans pseudohyphae do not
express the dectin-1 ligand b-glucan on their surface (Gantner
et al., 2005) and that the observedpatternwas lost inPBMCs lack-
ing dectin-1 expression on their membrane suggests an amplifi-
cation of b-glucan/dectin-1 on IL-17 production induced by other
C. albicans components (e.g., mannan). These observations are in
line with a recent study that suggests that dectin-1 signaling
through Syk-CARD9 represents an important pathway in the
Th17 response induced by C. albicans (Leibundgut-Landmann
et al., 2007). However, b-glucans alone were not able to induce
IL-17, and they did not give additional IL-17 production in combi-
nation with Candida mannan. Candida mannan induced signifi-
cant IL-17 production in the dectin-1-deficient patients, demon-
strating that the observed induction of IL-17 by Candida
mannan is not through dectin-1. Furthermore, IL-17 release
induced by heat-killed C. albicans was strongly inhibited by the
blockade of MR, demonstrating that IL-17 production is largely
dependent on the MR in the absence of dectin-1. These data
imply that the MR is the sole receptor that can directly lead to
IL-17 production in human PBMCs, and this pathway is amplified
by dectin-1/TLR2 signaling.
In the present study, we report a methodology to investigate
the pathogen-specific stimulation of Th17 cells in conditionsCelmimicking the in vivo situation. We demonstrate the strong
capacity of C. albicans to induce IL-17 production, and we
have deciphered the receptor pathways involved. However,
the data presented here also bring new questions into light and
open avenues for future research. First, one of the most inter-
esting observations regards the capacity of TLR2 ligation to
amplify MR-induced IL-17 on the one hand but to inhibit IFNg
production on the other hand. We and others have previously
shown that TLR2 engagement is not able to induce Th1 cyto-
kines (Hirschfeld et al., 2001; Netea et al., 2004; Re and Stro-
minger, 2001). The data presented here demonstrate that the
TLR2 pathway shifts the immune response toward a Th17
type, with important consequences for understanding patho-
physiology of disease. In addition, previous studies have shown
the capacity of TLR2 to induce TREG proliferation (Sutmuller et al.,
2006). It has been recently shown that FOXP3+ cells control the
secondary induction of RORgt, and TREG cells can be directed to
induce differentiation of Th17 cells in the presence of IL-6 (Xu
et al., 2007) or even differentiate themselves into Th17 cells
(Koenen et al., 2008). Our data suggest that TLR2 may play an
important role in this process, but future studies are needed to
assess this hypothesis in more detail. Second, an important
aspect to be investigated regards the pathways through which
MR induces IL-17. Indeed, a very recent study has demonstrated
that MR is recruited to the phagosome and has a crucial role for
cytokine induction by C. albicans (Heinsbroek et al., 2008).
However, the intracellular signaling induced by MR is yet
unknown, and the cytokine profile induced byMR that is respon-
sible for IL-17 induction is the first aim of future studies in our
laboratory. All cytokines known to be required for the induction
of IL-17—e.g., IL-23, IL-1b, and IL-6—are stimulated by MR
engagement by C. albicans or mannan, fulfilling a first set of
conditions necessary for IL-17 production. However, none of
these cytokines has been specifically induced only by or espe-
cially by MR, implying that an additional factor important for
IL-17 production is induced by MR recognition. Third, one has
to acknowledge that although C. albicans was by far the most
potent inducer of IL-17 production, the Gram-negative bacteria
Escherichia coli, K. pneumonia, and Salmonella enteritidis also
stimulated small amounts of IL-17. TLR and NOD2 ligands, alone
or in combination, did not stimulate IL-17 release, and therefore
the precise pathways through which Gram-negative bacteria
stimulate IL-17 production remain to be elucidated.
In conclusion, we have analyzed the innate receptors and
PAMPs responsible for inducing a Th17 response during
a specific pathogen-host interaction. In anti-C. albicans host
defense, the MR takes center stage in the induction of the Th17
response, and this pathway can be augmented by TLR2/dectin-
1. These data reveal a pathway leading to the induction of the
Th17 response in human PBMCs. The essential position played
by the MR warrants further investigation for its role in the Th17
response during infection or autoimmune diseases and might
lead to the design of novel immunotherapeutic strategies.
EXPERIMENTAL PROCEDURES
Volunteers
Bloodwas collected from ten healthy, nonsmoking volunteers whowere free of
infectious or inflammatory disease and from three patients who were defectivel Host & Microbe 5, 329–340, April 23, 2009 ª2009 Elsevier Inc. 337
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Macrophage Mannose Receptor and Th17in dectin-1 expression (B. Ferwerda, G. Ferwerda, T. Plantinga, J.A. Willment,
A.B. van Spriel, H. Venselaar, A. Cambi, C. Huysamen, L. Jacobs, T. Jansen, K.
Verheijen, L. Masthof, G. Vriend, D.L.W., L.A.B.J., J.W.M.v.d.M., G.J. Adema,
B.J.K., G.D. Brown, and M.G.N., unpublished data) after informed consent.
This was due to a single nucleotide polymorphism at position 238, leading to
a premature stop codon and a defective transport of the truncated dectin-1
protein to the cell surface. Blood samples were collected in 10 ml ethylenedia-
minetetraacetic acid (EDTA) tubes (BD Vacutainer; Plymouth, UK). Serum was
obtained from a patient with XLA after informed consent.
Reagents and Ligands
Bartonella LPS was used as a potent TLR4 inhibitor (anti-TLR4) (Popa et al.,
2007). TLR2-blocking antibody (anti-TLR2) and its control IgA1 (catalog
numbers maba-htlr2 and maba1-ctrl) were purchased from InvivoGen (San
Diego, CA). Anti-dectin-1 antibody GE2 (anti-dectin-1) was a kind gift of Dr.
Gordon Brown (University of Capetown, South Africa) (Willment et al., 2005).
Mannose macrophage antibody (anti-MR) (catalog number 555953, clone
19.2) was purchased from BD Biosciences (Dendermonde, Belgium). Match-
ing mIgG1 isotype control (anti-IgG) was purchased from R&D Systems (Min-
neapolis). E. coli LPS (serotype 055:B5) was purchased from Sigma (St. Louis),
repurified as previously described, and used as an ultra pure TLR4 ligand
(Hirschfeld et al., 2001). TLR ligands Pam3Cys, PolyI:C, Flagellin, and ODN
M362 were from InvivoGen (San Diego, CA). Synthetic MDP was purchased
from Sigma (St. Louis). Chitin was kindly provided by Professor Neil A.R.
Gow (School of Medical Scienses; Aberdeen, UK) and prepared according
to previous protocols (Gow and Gooday, 1987). Candidamannan and particu-
lated b-glucan were prepared as previously described (Kogan et al., 1988;
Lowman et al., 2003). Briefly, for Candida mannan: 100 g wet weight of yeast
biomass was suspended in 400 ml 2% (wt/vol) KOH and heated for 1 hr at
100C. Insoluble residues were separated by centrifugation, and mannan
was precipitated from supernatant with Fehling’s reagent. The sedimented
mannan-copper complex was dissolved in a minimum volume of 3 M HCl
and added drop wise to methanol/acetic acid at a ratio of 8:1 (vol/vol). The
procedure of dissolution and precipitation was repeated twice. Finally, the
sediment was separated, dissolved in distilled water, and dialyzed for 24 hr.
The purified mannan was considered to be maximally deproteinized. Protein
analysis by BCA Kit (Pierce) measured 0.77 mg/ml of protein in the preparation
of 100 mg/ml. Curdlan (Wako) is a dectin-1 ligand consisting of linear
b-1,3-glucan polymers derived from Alcaligenes faecalis (Yoshitomi et al.,
2005). Zymosan and mannan (lot 16H3842 from Saccharomyces cerevisiae)
were from Sigma (St. Louis). All stimulations with fungal ligands were in
a concentration of 10 mg/ml unless indicated otherwise. Beads were coated
with anti-CD3a alone or in combination with anti-CD28 and were prepared
according to the manufacturer’s instructions (Miltenyi Biotec; Utrecht, The
Netherlands).
Microorganisms
C. albicans ATCC MYA-3573 (UC 820), a strain well described elsewhere
(Lehrer and Cline, 1969), was used. C. albicans was grown overnight in Sabo-
uraud broth at 37C; cells were harvested by centrifugation, washed twice, and
resuspended in culture medium (RPMI-1640 Dutchmodification; ICN Biomed-
icals; Aurora, OH) (van der Graaf et al., 2005). To generate pseudohyphae,
C. albicans blastoconidia were grown at 37C in culture medium adjusted to
pH 6.4 by using hydrochloric acid. Pseudohyphae were killed for 1 hr at
100C and resuspended in culture medium to a hyphal inoculum size that orig-
inated from 106/ml blastoconidia (referred to as 106/ml pseudohyphae). All
stimulations with C. albicans were with a concentration of 106/ml unless indi-
cated otherwise. Clinical isolates of S. enteritidis, K. Pneumonia, and E. coli
were heat-killed and used in a dosage of 107/ml. A heat-killed clinical isolate
of S. cerevisiae was kindly provided by Professor Neil A.R. Gow and used in
a dosage of 106/ml (School of Medical Sciences; Aberdeen, UK).
In Vitro Cytokine Production
Separation and stimulation of PBMCs was performed as described previously
(Netea et al., 2006). Briefly, the PBMC fraction was obtained by density centri-
fugation of diluted blood (one part blood to one part pyrogen-free saline) over
Ficoll-Paque (Pharmacia Biotech; Uppsala). PBMCs were washed twice in
saline and suspended in culture medium supplemented with gentamicin 1%,338 Cell Host & Microbe 5, 329–340, April 23, 2009 ª2009 Elsevier IL-glutamine 1%, and pyruvate 1%. The cells were counted in a Bu¨rker count-
ing chamber, and their number was adjusted to 53 106 cells/ml. Five hundred
thousand PBMCs in a volume of 200 ml per well were incubated at 37C in
round-bottom 96-well plates (Greiner; Nuremberg, Germany), in the presence
of 10% human pooled serum (unless indicated otherwise), with stimuli or
culture medium alone. In blocking experiments, PBMCs were preincubated
for 1 hr with various inhibitors (anti-TLR4 100 ng/ml, anti-TLR2 10 mg/ml,
anti-Dectin-1 10 mg/ml, anti-MR 5 mg/ml, anti-IgG1 10 mg/ml) before stimula-
tion with C. albicans. After 48 hr or 5 days of incubation, supernatants were
collected and stored at 20C until assayed.
Cytokine Assays
Cytokine concentrations were measured by commercial ELISA kits: IL-1b,
IL-17, and TNF-a (R&D Systems); IL-6, IFNg, and IL-10 (Pelikine Compact,
Sanquin; Amsterdam); and IL-23 (eBioscience) according to the manufac-
turer’s instructions. IL-12p70 and IL-2 were measured using the Bio-Plex
(Luminex) cytokine assays from Bio-Rad (Hercules, CA), following the manu-
facturer’s instructions.
Intracellular Cytokine Staining
PBMC cells were stimulated for 4–6 hr with PMA (50 ng/ml) (Sigma) and iono-
mycine (1 mg/ml) (Sigma) in the presence of GolgiPlug (BD Biosciences)
according to manufacturers’ protocols. Cells were first extracellularly stained
using an anti-CD4 APC antibody (BD Biosciences). Subsequently, the cells
were fixed and permeabilized with Cytofix/Cytoperm solution (BD Biosci-
ences) and then intracellularly stained with anti-IFNg PE (eBiosciences) and
anti-IL-17 FITC (eBiosciences). Samples were measured on a FACS Calibur,
and data were analyzed using the CellQuest Pro software (BD Biosciences).
Cell Isolation, Stimulation, and Flow Cytometry
Isolation of CD4+ cells was performed as described previously (Koenen et al.,
2008). Purified CD4+ T cells were labeled with CD25-PE-conjugated mAb
(MA251) (BD Biosciences) and CD45RA-ECD-conjugated mAb (2H4) (Beck-
man Coulter; Mijdrecht, The Netherlands); thereafter, CD25negCD45RApos
and CD25negCD45RAneg cells were isolated by high-purity flow cytometric
cell sorting using an Altra cell sorter (BeckmanCoulter). A rerun was performed
to analyze the cell purity of the sorted cells; sorted cells were alwaysmore than
98% pure. Monocytes were positively isolated from PBMCs with magnetic
bead isolation using CD14 microbeads (Miltenyi-Biotec; Utrecht, The
Netherlands) according to the manufacturer’s instructions. Cells were cultured
in culture medium (RPMI-1640 with glutamax supplemented with pyruvate
[0.02 mM], 100 U/ml penicillin, 100 mg/ml streptomycin [all from GIBCO;
Paisley, UK], and 10% human pooled serum [HPS]) at 37C, 95% humidity,
and 5% CO2 in 96-well round-bottom plates (Greiner; Frickenhausen,
Germany). Sorted naive (CD25-CD45RA+) and memory (CD25-CD45RA)
cell (2.5 3 104) populations were cultured with or without autologous mono-
cytes (1.0 3 105) in 200 ml culture medium in the absence or presence of
stimuli. All stimuli were added at the start of the cultures. Cells were phenotyp-
ically analyzed by flow cytometry. The following conjugated mAbs were used:
CD3-(UCHT1) ECD-labeled (Beckman Coulter). Intracellular analysis of cyto-
kines was performed following stimulation for 4 hr with PMA (12.5 ng/ml)
plus ionomycin (500 ng/ml) in the presence of brefeldin A (5 mg/ml) (Sigma-
Aldrich). Cells were fixed and permeabilized using Fix and Perm reagents
(eBioscience) and subsequently stained with anti-IL-17-Alexa Fluor
647-(64DEC17) (eBioscience). Cell samples were measured on a FC500 flow
cytometer (Beckman Coulter), and flow cytometry data were analyzed using
CXP software (Beckman Coulter).
Quantitative PCR
PBMCs were cultured for 3 days, and RNA was extracted using TRI Reagent
(Sigma). The isolated RNA was treated with DNase to remove genomic DNA
andsubsequently reverse transcribedwitholigo(dT)primers ina reverse transcrip-
tase procedure with a total volume of 20 ml. Quantitative real-time PCR was per-
formed using the ABI/PRISM 7000Sequence Detection Systemwith primer pairs
and SYBR Green PCR Master Mix (Applied Biosystems). The sequences used
were as follows: IL-17A, forward 50-TTGATTGGAAGAAACAACGATGA-30 and
reverse 50-CTCAGCAGCAGTAGCAGTGACA-30; RORgt, forward 50-TGAGAAG
GACAGGGAGCCAA-30 and reverse 50-CCACAGATTTTGCAAGGGATCA-30;nc.
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CTTCTCTTTGCTGAAATAATACTGGTAGTC-30. Quantification of the PCR
signals was performed by comparing the cycle threshold (Ct) value of the gene
of interestwith theCtvaluesof the referencegeneGAPDH.All primersweredevel-
oped using Primer Express 2.0 (Applied Biosystems) and validated according to
the protocol. Values are expressed as fold increases of mRNA relative to that in
unstimulated cells.
siRNA Transfection
PBMCswere transfected by electroporation with the AmaxaHumanMonocyte
Nucleofector kit (Amaxa Inc.; Walkersville, MD) in accordance with the manu-
facturer’s instructions. In brief, PBMCs (2 3 107) were harvested and resus-
pended in 100 ml of nucleofector solution. After addition of MR siRNA
(011730) (Dharmacon, Inc.) or control GFP siRNA (VSC-1001) (Amaxa Inc.) at
final concentration of 125 nM, cells were electroporated with Amaxa program
Y-001 and recovered for 24 hr before further stimulation.
Statistical Analysis
The differences between groups were analyzed by a two-tailed paired t test.
Differences were considered statistically significant when p # 0.05, and the
actual P value is given for each test. All experiments were performed at least
twice, and the data are presented as the cumulative result of all experiments
performed, unless otherwise indicated.
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